Abstract
Structured strategies to tackle skin diseases and related infections provide a framework and direct actions against their burden. The World Health Organization (WHO) develops, updates, advocates, and disseminates international public health strategies and implementation tools including guidelines.
The 2016–2021 strategy to end sexually transmitted infections (STI) epidemic as a major public health concern, targets the 90:90:90 reduction of the global STI prevalence and national human papillomavirus (HPV) vaccine coverage. Standardized protocols and guidance which are people centered are needed to reach the targets, and interventions are mainly focused on prevention, management of asymptomatic patients, reaching sex partners and their treatment, access to STI services of adequate quality, and reducing the vulnerability and risks while meeting the needs of the general population with appropriate services.
Vector-borne infectious protozoa causing dermal complications such as lymphatic filariasis (LF) and leishmaniasis are to be targeted for elimination. The intervention and prevention strategies set up by the WHO for both of these protozoal infections overlap by interrupting the chain of transmission, monitoring the burden of disease, vector control of sandflies and mosquitoes, environmental management and protection, and control of animal reservoirs.
The HIV Global Health Strategy for 2016–2020 is a priority for the WHO and is based on accelerating actions and fast-tracking their responses. The WHO goal for HIV is the elimination of AIDS as a public health threat by 2030. The Strategy 2020 global targets are to reduce new HIV-infections and HIV-related deaths to fewer than 500,000 each and zero new infections among infants. The Five Strategic Directions are information for action, interventions for impact, delivering for equity, financing for sustainability, and innovation for acceleration.
Once leprosy was eliminated as a public health problem globally in 2000, the WHO global leprosy strategy focused on reducing leprosy-related disabilities. The 2016–2020 WHO Global Leprosy Strategy focuses on promoting early diagnosis to reduce the leprosy burden. The Strategy 2020 targets are zero new children diagnosed with leprosy and visible deformities, <1 per million newly diagnosed leprosy patients with visible deformities, and zero countries with legislation allowing discrimination on leprosy. The program five key operational strategies are focused on early and increased detection and coverage, universal contacts screening, uniform leprosy treatment, and interventions against stigma and discrimination.
Some non-governmental organizations, such as the International Society of Dermatology, have developed public health task forces and programs to promote skin health. Although the WHO has no specific public health strategies for general skin diseases in primary care, it has issued simple and practical clinical guidelines in the Integrated Management of Adolescent and Adult Illness for such diseases.
This is a preview of subscription content, log in via an institution.
References
The Global Guardian of Public Health, WHO. 2016. Assessed Aug 2016 http://www.who.int/about/what-we-do/global-guardian-public-health/en/
WHO handbook for guideline development. 2012. Assessed Aug 2016 http://www.who.int/kms/handbook_2nd_ed.pdf?ua=1
WHO Governing bodies site. Assessed Aug 2016, http://apps.who.int/gb/gov/
World Health Organization. Draft global health sector strategies sexually transmitted infections, 2016–2021; Sixty-ninth World Health Assembly. 2016. http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_33-en.pdf?ua=1
World Health Organization. WHO guidelines for the treatment of Chlamydia trachomatis. 2016. http://www.who.int/reproductivehealth/publications/rtis/chlamydia-treatment-guidelines/en/
World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae. 2016. http://www.who.int/reproductivehealth/publications/rtis/gonorrhoea-treatment-guidelines/en/
World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae. 2016 (in press).
World Health Organization. Leishmaniasis fact sheet. 2016. http://www.who.int/mediacentre/factsheets/fs375/en/
World Health Organization. Global Health Observatory Data, situation and trends. 2016. http://www.who.int/gho/neglected_diseases/leishmaniasis/en/
World Health Assembly. Sixty-sixth world health assembly, agenda item 16.2 Neglected tropical diseases. 2013. http://www.who.int/neglected_diseases/mediacentre/WHA_66.12_Eng.pdf?ua=1
World Health Organization. Integrating national programmes to eliminate lymphatic filariasis and onchocerciasis; strategic and technical advisory group for neglected tropical diseases subgroup on disease-specific indicators, 7–8 February 2015. 2015. http://apps.who.int/iris/bitstream/10665/246190/1/9789241511148-eng.pdf?ua=1
World Health Organization. Control of the leishmaniases; report of a meeting of the WHO expert committee on the control of Leishmaniases, Geneva, 22–26 March 2010. 2010. http://apps.who.int/iris/bitstream/10665/44412/1/WHO_TRS_949_eng.pdf?ua=1
World Health Organization. Recommended treatment regimen for Leishmaniasis. 2016. http://www.who.int/leishmaniasis/research/978924129496_pp67_71.pdf?ua=1
World Health Organization. Weekly epidemiological record; 17 September 2010; World Health Organization; 2010; Global programme to eliminate Lymphatic Filariasis, progress report 2000–2009 and strategic plan 2010–2020. 2010. http://apps.who.int/iris/bitstream/10665/44473/1/9789241500722_eng.pdf
World Health Organization. Lymphatic filariasis fact sheet. 2016. http://www.who.int/mediacentre/factsheets/fs102/en/
Global programme to eliminate lymphatic filariasis. http://www.who.int/wer/2010/wer8538a.pdf?ua=1
Summary records of the Sixty Seventh World Health Assembly of Committee A, twelfth meeting, section 9 (document WHA67/2013/rec/3).
Draft global health sector strategies, HIV 2016–2021, 22 April 2016. Sixty-ninth world health assembly.
Understanding fast-track: accelerating action to end the AIDS epidemic by 2030, see www.unaids.org/sites/default/filed/media_asset/201506_JC2743_Understanding_fasttrack_en.pdf
Global AIDS response progress reporting 2013 – Construction of core indicators for monitoring the 2011 UN political declaration on HIV/AIDS
Consolidated Guidelines on the use of antiretroviral drugs for treating and preventing HIV infection; recommendations for a public health approach – 2nd ed, WHO 2016.
Consolidated Guidelines on HIV testing Services; 5Cs: consent, confidentiality, counselling, correct results and connection; WHO, July 2015.
Global Leprosy Strategy. Accelerating towards a leprosy-free world. World Health Organization, Regional Office for South-East Asia; 2016.
Ryan TJ, Ersser SJ, Fuller LC. The public health intervention of skin care for all: community dermatology. In: Maddock J, editor. Public health – social and behavioral health. InTech; 2012. pp. 523–36.
Global Health Sector Strategy on HIV, 2016-2021
Consolidated Guidelines on the use of antiretroviral drugs for treating and preventing HIV infection; recommendations for a public health approach – 2 edition, WHO 2016.
Consolidated Strategic information Guidelines; for HIV in the health sector – WHO, May 2015.
Global AIDS response progress reporting 2013 – construction of core indicators for monitoring the 2011 UN political declaration on HIV/AIDS.
Leprosy
WHO Regional Office for South-East Asia Leprosy Programme. http://www.searo.who.int/entity/leprosy/en/
Skin Diseases in Primary Care
World Health Organization. Integrated management of adolescent and adult illness. Geneva: World Health Organization; 2004.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gerbase, A.C., Roman, G., Zemouri, C. (2018). International Public Health Strategies in Dermatology. In: Bonamigo, R., Dornelles, S. (eds) Dermatology in Public Health Environments. Springer, Cham. https://doi.org/10.1007/978-3-319-33919-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-33919-1_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33917-7
Online ISBN: 978-3-319-33919-1
eBook Packages: MedicineMedicine (R0)